USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Exploration of New Clinical Applications Drive Future Growth Potential
22-Apr-2022
Global
Market Research
K712-01-00-00-00
HC03533-GL-MT_26466
Deep brain stimulation (DBS) therapies target a growing number of existing indications, including movement disorders and neuropsychiatric conditions, and newer areas such as lifestyle disorders, including diabetes and obesity. This will allow more patients to benefit from the therapy. According to the WHO, neurological diseases currently contribute to 6.3% of the global disease burden and are among the major causes of mortality (as high as 16% in low- and middle-income countries). There is increasing awareness of the need for long-term solutions to improve overall brain health and associated neurological symptoms. Greater awareness will be important to boost the adoption of DBS solutions. Non-invasive access options, robot-assisted implantation, artificial intelligence, and state-of-the-art device design are among the technological advances expected to improve therapy efficiency and safety, rapidly accelerating DBS to become the standard of care. The study assesses the current market status and innovations in DBS technologies. Considering the overall DBS market trend toward precision, personalized, and remote care, the report highlights the top 3 growth opportunities in the space for medical device and technology companies to target.
Author: Kaustubh Suresh Savant
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the Deep Brain Stimulation Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Deep Brain Stimulation Segmentation
Growth Drivers for Deep Brain Stimulation
Growth Restraints for Deep Brain Stimulation
Global Burden of Deep Brain Stimulation Treated Indications
Global Burden of Deep Brain Stimulation Treated Indications (continued)
Evolution of Deep Brain Stimulation Therapy
DBS Therapy at Different Approval Stages for Different Indications
Competitor Ecosystem and Recent Development Activities
Key Competitors’ Product Portfolio
Digital Innovation Enabling Future Shift to Personalized and Remote Care
Supporting Digital Technologies Boost DBS Therapy Adoption
Key Takeaway—Top 5 Findings
Growth Opportunity 1—Integrating Digital Solutions for Patient-focused Care
Growth Opportunity 1—Integrating Digital Solutions for Patient-focused Care (continued)
Growth Opportunity 2—Facilitating Service Requirements to Expand into Developing Markets
Growth Opportunity 2—Facilitating Service Requirements to Expand into Developing Markets (continued)
Growth Opportunity 3—New Technology Research Focus to Gain Market Disruption Advantage
Growth Opportunity 3—New Technology Research Focus to Gain Market Disruption Advantage (continued)
List of Exhibits
Legal Disclaimer
List of Figures
- Deep Brain Stimulation: Growth Drivers, Global, 2022–2026
- Deep Brain Stimulation: Growth Restraints, Global, 2022–2025
- Deep Brain Stimulation: Distribution Potential by Patient, Global, 2020
- Deep Brain Stimulation: Therapy Evolution
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
15 Sep 2026 | Global | Market Research
Vendor Profiles: Advanced Wound Care Management Market, Global, 2025
The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...
11 Sep 2026 | Global | Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026
Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| Author | Kaustubh Suresh Savant |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| List of Charts and Figures | Deep Brain Stimulation: Growth Drivers, Global, 2022–2026~ Deep Brain Stimulation: Growth Restraints, Global, 2022–2025~ Deep Brain Stimulation: Distribution Potential by Patient, Global, 2020~ Deep Brain Stimulation: Therapy Evolution~ |
| Podcast | No |
| WIP Number | K712-01-00-00-00 |